Updated Recommendations for COVID-19 and Pneumococcal Vaccinations - 10/30/2024

This message includes updates on respiratory viruses from CDC.

Received this email from a friend? Sign up now

View this email in your web browser

October 30, 2024 This message includes updates on respiratory viruses from CDC.

Vaccines are an effective tool for protecting Americans against the most severe effects of many infectious diseases. Last week, CDC updated its vaccine recommendations for COVID-19 and pneumococcal disease based on advice from the Advisory Committee on Immunization Practices (ACIP).

Learn More

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised     CDC has updated the vaccine recommendations for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine 6 months after their first dose. These updated recommendations also allow for flexibility for additional doses (i.e., three or more) for those who are moderately or severely immunocompromised, in consultation with their healthcare provider (a strategy known as shared clinical decision making).   The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults and those who are immunocompromised, along with the currently available data on vaccine effectiveness and year-round circulation of COVID-19. It also provides clarity to healthcare providers on how many doses should be given per year to people who are moderately or severely immunocompromised and is meant to increase coverage of this second dose for that group.   Data continue to show that vaccination is important to protect the people most at risk for severe outcomes of COVID-19. Receiving the 2024-2025 COVID-19 vaccines can restore and enhance protection against the virus variants currently responsible for most infections and hospitalizations in the United States. COVID-19 vaccination also reduces the chance of suffering the effects of Long COVID, which can develop during or following acute infection and last for an extended duration.   CDC and ACIP will continue to monitor COVID-19 vaccine safety and effectiveness. CDC continues to recommend that everyone stay up to date on their COVID-19 vaccines, especially people 65 years of age and older and people with weakened immune systems.

Learn More

CDC updates its recommendation for pneumococcal vaccination lowering the starting age for all adults to 50 years old    CDC now recommends adults get vaccinated against pneumococcal disease at 50 years old, lowering the age from 65 years.   Lowering the age for pneumococcal vaccination gives more adults the opportunity to protect themselves from pneumococcal disease at the age when risk of infection substantially increases. Pneumococcal bacteria can cause serious illnesses, including pneumonia, meningitis, and bloodstream infections, and older adults are at increased risk for pneumococcal disease.   Adults 50 years or older should talk with a healthcare provider to make sure they’re up to date with pneumococcal vaccination. Now is a great time to get vaccinated against pneumococcal disease in preparation for the winter respiratory season. Learn More

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

CDC Updates | How to Protect Yourself in Respiratory Virus Season, Wild to Mild, Free COVID-19 Tests, and More! - 10/18/2024

This message includes updates on respiratory viruses from CDC.

Received this email from a friend? Sign up now

View this email in your web browser

October 18, 2024 This message includes updates on respiratory viruses from CDC.

Respiratory Virus Season: How to Protect Yourself and Others      As we welcome fall, it is a great time to make sure you and your family are taking steps to prevent respiratory diseases, including flu, COVID-19, and RSV. CDC’s respiratory virus guidance can help you stay healthy so you can continue to enjoy all the things you love to do this time of year.   We recommend that everyone use these core prevention strategies: Stay up to date with immunizations Practice good hygiene  Take steps for cleaner air When you may have a respiratory virus: Take steps to prevent spread Seek health care promptly for testing and/or treatment if you have risk factors for severe illness; early treatment may help lower your risk of severe illness You can also choose any or all of these additional strategies to further protect yourself and others: masks, physical distancing, and tests.   Every year, respiratory diseases such as flu, COVID-19, and RSV cause hundreds of thousands of hospitalizations and thousands of deaths during the fall and winter virus season. There are more tools than ever to protect ourselves, our families, and our communities from these diseases.

Learn More

Don’t Forget Your Flu Shot   Flu vaccines prevent millions of illnesses and flu-related doctor's visits each year. Seasonal flu vaccines are designed to protect against the three flu viruses that research indicates will be most common during the upcoming season. During seasons when flu vaccines are similar to circulating flu viruses, a flu vaccine can reduce the risk of having to go to the doctor with flu by 40% to 60%. For people who get vaccinated but still get sick, flu vaccine has been shown to reduce severity of illness.   Everyone 6 months and older, with rare exception, should get a flu vaccine every season. Vaccination is particularly important for people who are at higher risk of serious complications from flu.   Ideally, people should get vaccinated by the end of October. Most health insurance plans cover an annual flu vaccine as preventive care. Flu vaccination is often available at no or low cost to people who do not have insurance. Learn More

Order Four Free At-Home COVID-19 Tests Today  Every home in the U.S. is eligible to order four free at-home COVID-19 tests. Testing can help you know if you have COVID-19 so you can decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading the virus to others.   Ordering tests is easy and takes only a few minutes. Visit COVIDTests.gov and have over-the-counter tests delivered right to your mailbox.   The U.S. government also continues to make COVID-19 tests available to people who are uninsured and underserved communities through existing outreach programs, ranging from local food banks to libraries. Free or low-cost testing also may be available at certain health centers and Increasing Community Access to Testing locations near you. Learn More

Global Handwashing Day  On October 15, CDC joined with global partners and colleagues to celebrate Global Handwashing Day and raise awareness about the importance of handwashing with soap and water. Handwashing with soap and water is simple and inexpensive, and it can significantly reduce the number of young children who get sick.   Hygiene, or practices that improve cleanliness, is a core prevention strategy to lower risk from respiratory viruses. Steps you can take: Cover your mouth and nose with a tissue when you cough or sneeze. Throw used tissues in the trash. If you don't have a tissue, cough or sneeze into your elbow, not your hands. Learn and use proper handwashing technique. Teach children the correct way to wash their hands. Clean frequently touched surfaces, such as countertops, handrails, and doorknobs, regularly. Learn More

	Respiratory Virus Data Channel Weekly Snapshot   The Respiratory Virus Weekly Snapshot provides an update on COVID-19, flu, and RSV activity nationally and in your state. Check back every Friday for the latest data.  Learn More

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

RSV Immunizations – 9/26/2024

This message includes updates on respiratory viruses from CDC.

Received this email from a friend? Sign up now

View this email in your web browser

September 26, 2024 This message includes updates on respiratory viruses from CDC.

RSV can be dangerous for babies and older adults. We are entering the second year where RSV immunizations will be available to protect these groups from severe RSV. There is one set of recommendations for older adults, and a separate set – which includes two immunization options – to protect babies.

RSV Vaccines for Older Adults     CDC recommends a single dose of an RSV vaccine for everyone ages 75 and older and for people ages 60–74 who are at increased risk of severe RSV. Adults ages 60-74 are considered at increased risk if they have one or more of the following risk factors: Chronic heart or lung disease A weakened immune system Certain other medical conditions*, including diabetes with complications and severe obesity Live in a nursing home *For a complete list of chronic health issues that lead to increased risk of severe RSV, see Clinical Overview of RSV.   If you have already gotten an RSV vaccine, you do not need to get another one at this time.   How well do these vaccines work? Real-world data gathered during the 2023-2024 RSV season show that RSV vaccines reduced the risk of RSV-associated hospitalization or emergency department visits by 75%-80%. Importantly, these data include populations that are at highest risk for severe RSV, including those ages 75 and older, those who are immunocompromised, and those who live in nursing homes.   If you are eligible for an RSV vaccine, the best time to get vaccinated is now (late summer through early fall) – before the RSV season starts!

Learn More

RSV Immunizations to Protect Infants  CDC recommends all babies be protected from severe RSV by one of two immunization options: A maternal RSV vaccine (Pfizer’s Abrysvo) given to the mother during weeks 32 – 36 of pregnancy An RSV antibody (nirsevimab) given to the baby. RSV antibody should be administered in the first week after birth – ideally during the birth hospitalization, or shortly before the RSV season if they are born outside of RSV season. Nirsevimab is also recommended for a small group of young children 8 – 19 months of age who are at increased risk for severe RSV. Most babies will not need both.   Both RSV immunizations to protect infants are administered during specific months, detailed here: * For infants born outside of this window (April – September) and for young children who are at increased risk for severe RSV disease and entering their second RSV season, the optimal timing for nirsevimab administration is shortly before the RSV season begins (October or November).   How good are these immunizations at protecting babies? Early real-world data show that nirsevimab was 80-90% effective in preventing babies from being hospitalized with RSV. It provides immediate protection against RSV and lasts at least 5 months.   CDC continues to gather real-world effectiveness data for maternal RSV vaccine (Pfizer’s Abrysvo). Our best data at this time continues to be from the phase 3 clinical trial, which showed the maternal RSV vaccine reduced the risk of the baby being hospitalized for RSV by 68% and the risk of having a healthcare visit for RSV by 57% within 3 months after birth. Additional data shows that maternal antibodies protect the baby against RSV for approximately 6 months after birth.   Whether you're a healthcare provider, a caretaker, or at risk of RSV yourself, you can help fight against RSV by learning and sharing CDC's recommendations with others. Learn More

Respiratory Virus Data Channel Weekly Snapshot  The Respiratory Virus Weekly Snapshot provides an update on COVID-19, flu, and RSV activity nationally and in your state. Check back every Friday for the latest data. Learn More

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe